Management to Hold Investor Day Conference Call Today at 10:00am ETReported record product revenue of $11.6 million in Q4 2024, an increase of ...
4d
Company’s patented desmopressin oral solution successfully passed pivotal bioequivalence study -- Company expects to submit New Drug ...
Eton Pharmaceuticals (NASDAQ:ETON – Get Free Report) will likely be issuing its quarterly earnings data before the market opens on Thursday, March 13th. Analysts expect the company to announce ...
ST. LOUIS, March 04, 2025 (GLOBE NEWSWIRE) -- Optime Care, a nationally recognized specialty pharmacy and an AscellaHealth Company, today announces an expanded partnership with Eton Pharmaceuticals ...
Eton Pharmaceuticals, Inc. (“Eton” or the "Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare ...
(MENAFN- GlobeNewsWire - Nasdaq) ST. LOUIS, March 04, 2025 (GLOBE NEWSWIRE) -- Optime Care , a nationally recognized specialty pharmacy and an AscellaHealth Company, today announces an expanded ...
ST. LOUIS, March 04, 2025 (GLOBE NEWSWIRE) -- Optime Care, a nationally recognized specialty pharmacy and an AscellaHealth Company, today announces an expanded partnership with Eton ...
DEER PARK, Ill., March 03, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing ...
DEER PARK, Ill., March 03, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the“Company”) (Nasdaq: ETON), an innovative Pharmaceutical company focused on developing and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback